|
Name |
Isosulochrin
|
| Molecular Formula | C17H16O7 | |
| IUPAC Name* |
methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate
|
|
| SMILES |
CC1=CC(=C(C(=C1)O)C(=O)C2=C(C=C(C=C2O)OC)C(=O)OC)O
|
|
| InChI |
InChI=1S/C17H16O7/c1-8-4-11(18)15(12(19)5-8)16(21)14-10(17(22)24-3)6-9(23-2)7-13(14)20/h4-7,18-20H,1-3H3
|
|
| InChIKey |
XKIBNYJGNBTYMP-UHFFFAOYSA-N
|
|
| Synonyms |
Isosulochrin; O8CBB83PPJ; 77282-68-9; methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate; Methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybe..; Benzoic acid, 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxy-, methyl ester; UNII-O8CBB83PPJ; MLS000877019; MEGxm0_000016; CHEMBL1387766; ACon0_000933; ACon1_000868; DTXSID501346187; HMS2269B13; ZINC13660257; NCGC00169280-01; SMR000440672; BRD-K50598371-001-01-6; Q27285475; Methy 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate; NCGC00169280-03!methyl 2-(2,6-dihydroxy-4-methylbenzoyl)-3-hydroxy-5-methoxybenzoate
|
|
| CAS | 77282-68-9 | |
| PubChem CID | 16681742 | |
| ChEMBL ID | CHEMBL1387766 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 332.3 | ALogp: | 2.9 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 113.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 24 | QED Weighted: | 0.583 |
| Caco-2 Permeability: | -5.086 | MDCK Permeability: | 0.00001240 |
| Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.098 | 20% Bioavailability (F20%): | 0.034 |
| 30% Bioavailability (F30%): | 0.82 |
| Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 98.77% |
| Volume Distribution (VD): | 0.394 | Fu: | 2.72% |
| CYP1A2-inhibitor: | 0.949 | CYP1A2-substrate: | 0.916 |
| CYP2C19-inhibitor: | 0.435 | CYP2C19-substrate: | 0.062 |
| CYP2C9-inhibitor: | 0.696 | CYP2C9-substrate: | 0.825 |
| CYP2D6-inhibitor: | 0.529 | CYP2D6-substrate: | 0.351 |
| CYP3A4-inhibitor: | 0.664 | CYP3A4-substrate: | 0.141 |
| Clearance (CL): | 11.79 | Half-life (T1/2): | 0.582 |
| hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.049 |
| Drug-inuced Liver Injury (DILI): | 0.95 | AMES Toxicity: | 0.732 |
| Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.856 |
| Skin Sensitization: | 0.288 | Carcinogencity: | 0.028 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.943 |
| Respiratory Toxicity: | 0.147 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005979 | ![]() |
0.795 | D07MGA | ![]() |
0.289 | ||
| ENC000936 | ![]() |
0.778 | D06GCK | ![]() |
0.279 | ||
| ENC004806 | ![]() |
0.770 | D04AIT | ![]() |
0.271 | ||
| ENC002109 | ![]() |
0.711 | D0Y7PG | ![]() |
0.269 | ||
| ENC002663 | ![]() |
0.634 | D00KRE | ![]() |
0.265 | ||
| ENC005169 | ![]() |
0.628 | D0B0AX | ![]() |
0.263 | ||
| ENC002461 | ![]() |
0.618 | D04OSE | ![]() |
0.260 | ||
| ENC002468 | ![]() |
0.617 | D0R1RS | ![]() |
0.255 | ||
| ENC005978 | ![]() |
0.617 | D0K8KX | ![]() |
0.253 | ||
| ENC005170 | ![]() |
0.612 | D0A1DH | ![]() |
0.252 | ||